Skip to Main Content

Advertisement

American Association of Immunologists Journals
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 6, Issue 4
1 April 2022
Issue Cover
EISSN 2573-7732
In this Issue

EDITORIAL

The Statue of Publication Liberty
Mark H. Kaplan
Immunohorizons (2022) 6 (4): 273–274.
View articletitled, The Statue of Publication Liberty
Open the PDF for in another window
Add to Citation Manager

INNATE IMMUNITY

LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance
Moriya Shmerling; Michael Chalik; Nechama I. Smorodinsky; Alan Meeker; Sujayita Roy; Orit Sagi-Assif; Tsipi Meshel; Artem Danilevsky; Noam Shomron; Shmuel Levinger; Bar Nishry; David Baruchi; Avital Shargorodsky; Ravit Ziv; Avital Sarusi-Portuguez; Maoz Lahav; Marcelo Ehrlich; Bryony Braschi; Elspeth Bruford; Isaac P. Witz; Daniel H. Wreschner
Immunohorizons (2022) 6 (4): 253–272.
View articletitled, <em>LY6S,</em> a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance
Supplementary data
Open the PDF for in another window
Add to Citation Manager
Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model
Naoko Iwata-Yoshikawa; Noriyo Nagata; Hiromi Takaki; Misako Matsumoto; Tadaki Suzuki; Hideki Hasegawa; Tsukasa Seya
Immunohorizons (2022) 6 (4): 275–282.
View articletitled, Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model
Open the PDF for in another window
Add to Citation Manager
All Issues

Advertisement

Advertisement

Advertisement

  • Online ISSN 2573-7732

Publications

Submit a Manuscript

General Information

Journal Services

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept